
Compounded GLP-1 Vial Mix-Ups: Why Units and Milliliters Cause Overdoses
The FDA has received reports of people hospitalized after measuring compounded semaglutide in the wrong units. How a multi-dose vial creates that risk, and...
Read more →
The FDA has received reports of people hospitalized after measuring compounded semaglutide in the wrong units. How a multi-dose vial creates that risk, and...
Read more →
Retatrutide is still in clinical trials and is not approved anywhere, yet vials are sold as research chemicals. Why trial results do not transfer...
Read more →
Compounders could copy semaglutide while it was on the FDA shortage list. The FDA declared the shortage over on February 21, 2025, and the...
Read more →